CNS part 3 Flashcards
dopaminergic agents
increase effects of dopamine at receptor sites
more effective than anticholinergics
carbidopa-levodopa (sinemet) indications
Parkinson disease
carbidopa-levodopa (sinemet) action
levodopa: a dopamine precursor that relieves parkinsonian symptoms by being converted to dopamine in the braine
carbidopa: inhibits decarboxylation of peripheral levodopa which allows more intact levodopa to travel to the brain
carbidopa-levodopa (sinemet) contraindications
glaucoma hx melanoma suicidal thoughts, bipolar disorder renal, hepatic, respiratory disorders peptic ulcer disease
carbidopa-levodopa (sinemet) adverse effects
anxiety, nervousness photophobia, blurred vision flushing, sweating hypotension, arrhythmia anorexia, nausea, constipation urinary retention teratogenic
carbidopa-levodopa (sinemet) interactions
high protein meals, iron salts, antipsychotics, metoclopramide: decreased action/effect of carbidopa-levodopa
anticholinergics: increased response to carbidopa-levodopa
phenytoin: may antagonize antiparkinsonian action
carbidopa-levodopa (sinemet) interventions
monitor for s/s orthostatic hypotension
changes in client urine/sweat color
give quetiapine to relieve psychotic sx
give COMT inhibitor to increase half-life of levodopa and deliver more to the brain
carbidopa-levodopa (sinemet) pt teaching
take with food to avoid GI distress darkening of urine/sweat may occur change positions slowly avoid high protein foods can take up to 6 months for full response
anticholinergic agents
oppose the effects of acetylcholine at receptor sites in the substantia nigra and the corpus striatum, thus helping to restore chemical balance in the area
benztropin (cogentin) indications
adjunctive therapy for parkinson disease
relief of symptoms of extrapyramidal disorders
benztropin (cogentin) action
acts as an anticholinergic in CNS to return balance to basal ganglia
peripheral anticholinergic effects help reduce drooling and other secondary effects of parkinsonism
benztropin (cogentin) contraindications
angle closure glaucoma
anhidrosis
arrhythmias
seizure disorders
benztropin (cogentin) adverse effects
memory impairment, depression, hallucinations, fever tachycardia, arrhythmias dilated pupils, dry mouth constipation, n/v/d, paralytic ileus urinary retention, dysuria sweating, heat stroke
benztropin (cogentin) interactions
amantadine, TCAs: may cause additive anticholinergic adverse reactions
cholinergics (donepezil, rivastigmine): may antagonize therapeutic effects
benztropin (cogentin) interventions
monitor vital signs
monitor for adverse effects especially in elderly pts
recognize s/s paralytic ileus (intermittent constipation and abdominal distention and pain)
benztropin (cogentin) pt education
take dose at bedtime
report s/s dysuria, retention
limit hot weather activity; risk of overheating
dopamine agonists
medications that mimic the actions of dopamine in the body to relieve symptoms related to low levels of dopamine
pramipexole (mirapex) indications
idiopathic parkinsonism
restless leg syndrome
pramipexole (mirapex) action
stimulates dopamine receptors